SCHEMBL7403728

SCHEMBL7403728

Cc1c(Cl)nc(NCCC2CC2)c(=O)n1CC(=O)OCc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
TPSAB1 Q15661 13/20 0.49
F2 P00734 2/20 0.47
F7 P08709 1/20 0.47
F3 P13726 1/20 0.47
PRSS1 P07477 1/20 0.47
PLAU P00749 1/20 0.40
BCHE P06276 3/20 0.40
ACHE P22303 3/20 0.40
CACNA1F O60840 1/20 0.40
CACNA1D Q01668 1/20 0.40
CACNA1S Q13698 1/20 0.40
CACNA1C Q13936 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3247707 0.88 F2 (0.60) TPSAB1F2F7F3PRSS1
SCHEMBL8205180 0.87 TPSAB1 (0.52) TPSAB1F2F7F3PRSS1
SCHEMBL5885589 0.84 F2 (0.59) TPSAB1F2F7F3PRSS1
SCHEMBL7021913 0.83 F2 (0.42) TPSAB1F2F7F3PRSS1
SCHEMBL7023919 0.83 TPSAB1 (0.47) TPSAB1F2F7F3PRSS1
SCHEMBL7694668 0.83 TPSAB1 (0.47) TPSAB1F2F7F3PRSS1
SCHEMBL7020466 0.82 TPSAB1 (0.43) TPSAB1F2F7F3PRSS1
SCHEMBL7029085 0.82 TPSAB1 (0.43) TPSAB1F2F7F3PRSS1
SCHEMBL7018545 0.82 TPSAB1 (0.43) TPSAB1F2F7F3PRSS1
SCHEMBL7140320 0.82 F2 (0.47) TPSAB1F2F7F3PRSS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0900207-B1 PYRAZINONE THROMBIN INHIBITORS MERCK & CO INC (US) 2001-11-21 EP disclosed
EP-0900207-A1 PYRAZINONE THROMBIN INHIBITORS Merck & Co., Inc. (US) 1999-03-10 EP disclosed
US-5866573-A Pyrazinone thrombin inhibitors MERCK & CO., INC. (US) 1999-02-02 US disclosed
WO-1997040024-A1 PYRAZINONE THROMBIN INHIBITORS MERCK & CO., INC. (US) 1997-10-30 WO disclosed